Mesenchymal Stem Cells As a Feeder Layer Can Prevent Apoptosis of Expanded Hematopoietic Stem Cells Derived from Cord Blood

Overview

Journal Int J Mol Cell Med

Specialty Genetics

Date 2014 Feb 20

PMID 24551815

Citations 15

Authors

Roya Mehrasa

Hamidreza Vaziri

Arezoo Oodi

Mona Khorshidfar

Mahin Nikogoftar

Monireh Golpour

Naser Amirizadeh

Affiliations

Soon will be listed here.

Abstract

Umbilical cord blood (UCB) has been used for transplantation in the treatment of hematologic disorders as a source of hematopoietic stem cells (HSCs). Because of insufficient number of cord blood CD34(+) cells, the expansion of these cells seems to be important for clinical application. Mesenchymal stromal cells (MSCs), playing an important role in HSCs maintenance, were used as feeder layer. Apoptosis and cell cycle distribution of expanded cells were analyzed in MSCs co-culture and cytokine conditions and results were compared. Three culture conditions of cord blood HSCs were prepared ex-vivo for 14 days: cytokines (SCF, TPO and Flt3L) with MSCs feeder layer, cytokines without MSCs feeder layer and co-culture with MSCs without cytokines. Expansion was followed by measuring the total nucleated cells (TNCs), CD34(+) (‏) cells and colony-forming unit (CFU) output. Flow cytometry analysis of stained cells by annexin V and propidium iodide was performed for detection of apoptosis rate and cell cycle distribution in expanded cells. Maximum cord blood CD34(+) cells expansion was observed in day 10. The mean fold change of TNCs and CD34+ cells at day 10 in the co-culture system with cytokines was significantly higher than the cytokine culture without MSCs feeder layer and co-culture system without cytokines (n=6, p=0.023). The highest apoptosis rate and the least number of cells in Go/G1 phase were observed in cytokine culture without feeder layer (p=0.041). The expansion of cord blood HSCs on MSCs as a feeder layer resulted in higher proliferation and reduction in apoptosis rate.

Citing Articles

Mesenchymal stem cells cause induction of granulocyte differentiation of rat bone marrow C-kit hematopoietic stem cells through JAK3/STAT3, ERK, and PI3K signaling pathways.

Fathi E, Mesbah-Namin S, Vietor I, Farahzadi R Iran J Basic Med Sci. 2022; 25(10):1222-1227.

PMID: 36311196 PMC: 9588313. DOI: 10.22038/IJBMS.2022.66737.14633.

Mesenchymal stromal cell-derived extracellular vesicles: novel approach in hematopoietic stem cell transplantation.

Pashoutan Sarvar D, Effatpanah H, Akbarzadehlaleh P, Shamsasenjan K Stem Cell Res Ther. 2022; 13(1):202.

PMID: 35578300 PMC: 9109321. DOI: 10.1186/s13287-022-02875-3.

Stem cell therapy: old challenges and new solutions.

Balistreri C, De Falco E, Bordin A, Maslova O, Koliada A, Vaiserman A Mol Biol Rep. 2020; 47(4):3117-3131.

PMID: 32128709 DOI: 10.1007/s11033-020-05353-2.

Wharton's jelly mesenchymal stem cell-based or umbilical vein endothelial cell-based serum-free coculture with cytokines supports the ex vivo expansion/maintenance of cord blood hematopoietic stem/progenitor cells.

Li Q, Zhao D, Chen Q, Luo M, Huang J, Yang C Stem Cell Res Ther. 2019; 10(1):376.

PMID: 31806004 PMC: 6894464. DOI: 10.1186/s13287-019-1502-8.

A Fluidic Culture Platform for Spatially Patterned Cell Growth, Differentiation, and Cocultures.

Lembong J, Lerman M, Kingsbury T, Civin C, Fisher J Tissue Eng Part A. 2018; 24(23-24):1715-1732.

PMID: 29845891 PMC: 6302678. DOI: 10.1089/ten.TEA.2018.0020.

References

Broxmeyer H . Umbilical cord transplantation: epilogue. Semin Hematol. 2010; 47(1):97-103. PMC: 3312374. DOI: 10.1053/j.seminhematol.2009.10.002. View

Jang Y, Jung D, Jung M, Kim D, Yoo K, Sung K . Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells. Ann Hematol. 2006; 85(4):212-25. DOI: 10.1007/s00277-005-0047-3. View

Tung S, Parmar S, Robinson S, de Lima M, Shpall E . Ex vivo expansion of umbilical cord blood for transplantation. Best Pract Res Clin Haematol. 2010; 23(2):245-57. DOI: 10.1016/j.beha.2010.06.004. View

Alvarado-Moreno A, Chavez-Gonzalez A, Cerbulo A, Arriaga L, Mayani H . In vitro cell cycle dynamics of primitive hematopoietic cells from human umbilical cord blood. Hematology. 2010; 15(1):11-20. DOI: 10.1179/102453310X12583347010016. View

Alenzi F, Alenazi B, Ahmad S, Salem M, Al-Jabri A, Wyse R . The haemopoietic stem cell: between apoptosis and self renewal. Yale J Biol Med. 2009; 82(1):7-18. PMC: 2660591. View

Conrad P, Emerson S . Ex vivo expansion of hematopoietic cells from umbilical cord blood for clinical transplantation. J Leukoc Biol. 1998; 64(2):147-55. DOI: 10.1002/jlb.64.2.147. View

Wagner W, Saffrich R, Ho A . The Stromal Activity of Mesenchymal Stromal Cells. Transfus Med Hemother. 2011; 35(3):185-193. PMC: 3083286. DOI: 10.1159/000128956. View

Zou J, Zou P, Wang J, Li L, Wang Y, Zhou D . Inhibition of p38 MAPK activity promotes ex vivo expansion of human cord blood hematopoietic stem cells. Ann Hematol. 2012; 91(6):813-23. PMC: 3390192. DOI: 10.1007/s00277-011-1397-7. View

Dahlberg A, Delaney C, Bernstein I . Ex vivo expansion of human hematopoietic stem and progenitor cells. Blood. 2011; 117(23):6083-90. PMC: 3122936. DOI: 10.1182/blood-2011-01-283606. View

10.

Wagner W, Saffrich R, Wirkner U, Eckstein V, Blake J, Ansorge A . Hematopoietic progenitor cells and cellular microenvironment: behavioral and molecular changes upon interaction. Stem Cells. 2005; 23(8):1180-91. DOI: 10.1634/stemcells.2004-0361. View

11.

Kerr W . Analysis of apoptosis in hematopoietic stem cells by flow cytometry. Methods Mol Biol. 2008; 430:87-99. DOI: 10.1007/978-1-59745-182-6_6. View

12.

Yildirim S, Boehmler A, Kanz L, Mohle R . Expansion of cord blood CD34+ hematopoietic progenitor cells in coculture with autologous umbilical vein endothelial cells (HUVEC) is superior to cytokine-supplemented liquid culture. Bone Marrow Transplant. 2005; 36(1):71-9. DOI: 10.1038/sj.bmt.1705001. View

13.

Wagner J, Barker J, DeFor T, Baker K, Blazar B, Eide C . Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood. 2002; 100(5):1611-8. DOI: 10.1182/blood-2002-01-0294. View

14.

Oguro H, Iwama A . Life and death in hematopoietic stem cells. Curr Opin Immunol. 2007; 19(5):503-9. DOI: 10.1016/j.coi.2007.05.001. View

15.

Wulf-Goldenberg A, Eckert K, Fichtner I . Cytokine-pretreatment of CD34(+) cord blood stem cells in vitro reduces long-term cell engraftment in NOD/SCID mice. Eur J Cell Biol. 2007; 87(2):69-80. DOI: 10.1016/j.ejcb.2007.08.001. View

16.

Traycoff C, Orazi A, Ladd A, Rice S, McMahel J, Srour E . Proliferation-induced decline of primitive hematopoietic progenitor cell activity is coupled with an increase in apoptosis of ex vivo expanded CD34+ cells. Exp Hematol. 1998; 26(1):53-62. View

17.

Delaney C, Ratajczak M, Laughlin M . Strategies to enhance umbilical cord blood stem cell engraftment in adult patients. Expert Rev Hematol. 2010; 3(3):273-83. PMC: 2935587. DOI: 10.1586/ehm.10.24. View

18.

Song Y, Bahnson A, Hall N, Yu H, Shen H, Koebler D . Stem cell traits in long-term co-culture revealed by time-lapse imaging. Leukemia. 2009; 24(1):153-61. PMC: 2806505. DOI: 10.1038/leu.2009.191. View

19.

Lobato da Silva C, Goncalves R, Crapnell K, Cabral J, Zanjani E, Almeida-Porada G . A human stromal-based serum-free culture system supports the ex vivo expansion/maintenance of bone marrow and cord blood hematopoietic stem/progenitor cells. Exp Hematol. 2005; 33(7):828-35. DOI: 10.1016/j.exphem.2005.03.017. View